Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection-Reference-Cited by-同舟云学术

Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection

Published:2015-02-27 Issue:2 Volume:10 Page:e0118228
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Amin Janaki,Boyd Mark A.,Kumarasamy Nagalingeswaran,Moore Cecilia L.,Losso Marcello H.,Nwizu Chidi A.,Mohapi Lerato,Kerr Stephen J.,Sohn Annette H.,Teppler Hedy,Renjifo Boris,Molina Jean-Michel,Emery Sean,Cooper David A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference19 articles.

1. WHO (2010) Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. Geneva.

2. Humphreys EH, Chang LW, Harris J (2010) Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. Cochrane Database Syst Rev: CD006517.

3. Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study;MA Boyd;Lancet,2013

4. Assessment of second-line antiretroviral regimens for HIV therapy in Africa;NI Paton;N Engl J Med,2014

5. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group;AS Levey;Ann Intern Med,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

2. Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D ² EFT;HIV Research & Clinical Practice;2022-08-08

3. Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective;AIDS;2021-12-15

4. Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1;Infectious Diseases and Therapy;2020-03-19

5. Efficacy and Safety of Raltegravir-Based Dual Therapy in AIDS Patients: A Meta-Analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2019-10-17